|
|
| Quarterly Results |
|
| Gland Pharma Ltd | | Industry : Pharmaceuticals - Indian - Formulations | Chairman : Yiu Kwan Stanley Lau | | Home : MNC Associate | Book Value: 509.8961438 | | BSE Code : 543245 | Market Cap: 28189.38 | | NSE Code : GLAND | P / E : 33.73 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 1097.86 | 1010.67 | 884.07 | 785.42 | | Other Income | 43.39 | 41.11 | 35.21 | 38.94 | | Total Income | 1141.25 | 1051.78 | 919.28 | 824.36 | | Total Expenditure | 728.37 | 663.57 | 624.71 | 672.73 | | Operating Profit | 412.88 | 388.21 | 294.57 | 151.63 | | Interest | 0.80 | 0.91 | 1.60 | 2.18 | | Gross Profit | 412.08 | 387.30 | 292.97 | 149.45 | | Depreciation | 40.33 | 40.24 | 38.98 | 37.54 | | Tax | 91.35 | 86.58 | 58.88 | 43.20 | | Deferred Tax | 3.60 | 2.95 | 7.53 | -10.50 | | Reported Profit After Tax | 276.81 | 257.53 | 187.58 | 79.21 |
|
|
|
|
|